| 000 -LEADER |
|---|
| fixed length control field |
04087nam a22004335i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20140310150246.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
111125s2012 au | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783709108703 |
|
978-3-7091-0870-3 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
QR186.7-186.85 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.0798 |
| Edition number |
23 |
|
|---|
| Classification number |
571.967 |
| Edition number |
23 |
| 264 #1 - |
|---|
| -- |
Vienna : |
| -- |
Springer Vienna : |
| -- |
Imprint: Springer, |
| -- |
2012. |
| 912 ## - |
|---|
| -- |
ZDB-2-SBL |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Kosma, Paul. |
| Relator term |
editor. |
| 245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
Anticarbohydrate Antibodies |
| Medium |
[electronic resource] : |
| Remainder of title |
From Molecular Basis to Clinical Application / |
| Statement of responsibility, etc |
edited by Paul Kosma, Sven Müller-Loennies. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
XIII, 438 p. |
| Other physical details |
online resource. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1 Antibodies and Synthetic Vaccines against Shigella O-Antigens -- 2 Synthetic Oligosaccharide Bacterial Antigens to Produce Monoclonal Antibodies for Diagnosis and Treatment of Disease Using Bacillus anthracis as a Case Study -- 3 The Role of Sialic acid in the Formation of Protective Conformational Bacterial Polysaccharide Epitopes -- 4 Antibody Recognition of Chlamydia LPS: Structural Insights of Inherited Immune Responses.- 5 Designing a Candida albicans Conjugate Vaccine by Reverse Engineering Protective Monoclonal Antibodies.- 6 Binding Properties, Structural Significances and Production of the Neutralizing Anti-HIV Antibody 2G12.- 7 Immune Recognition of Parasite Glycans -- 8 Human IgE Antibodies against Cross-reactive Carbohydrate Determinants.- 9 Structural Glycobiology of Antibody Recognition in Xenotransplantation and Cancer Immunotherapy -- 10 Carbohydrate Mimetic Peptide Vaccines -- 11 Antitumor Vaccines Based on Mucin Glycopeptides -- 12 Glycan Microarray Analysis of Tumor Specific Antibodies -- 13 Mannose-6-phosphate Specific Antibody and its Use in Diagnostics of Mucolipidosis -- 14 Anti-Glycolipid Antibodies in Guillain-Barré Syndrome and related Neurapathies: Therapeutic Strategies for Disease Treatment -- 15 Computational Techniques Applied to Defining Carbohydrate Antigenicity -- 16 The Interaction of Saccharides with Antibodies. A 3D View using NMR -- 17 Determination of Antibody Affinity by Surface Plasmon Resonance. . |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Anticarbohydrate Antibodies – from molecular basis to clinical application compiles current knowledge on the immunological recognition of carbohydrates by the adaptive immune system from a molecular perspective providing fundamental insight needed for advancing clinically relevant diagnostics and therapeutic applications. Based on significant progress in the fields of glycoimmunology and structural biology in recent years, the book comprehensively reviews the state-of-the-art in defining the key elements of carbohydrate recognition by antibodies, the molecular mimicry of carbohydrate epitopes as well as the molecular features leading to specific and relaxed binding modes. Backed-up by a combination of modern technologies to elucidate structural details of carbohydrate-antibody interactions, biomedically important carbohydrate antigens from viral, bacterial, parasite, insect and tumor cells have been analyzed in in-depth reviews written by well-known experts in the field. Fundamental knowledge of these molecular mechanisms eventually provides a rational basis to improve efficacy of carbohydrate-based vaccines and to further refine diagnostic tools in detection of pathogens and malignant cells. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Medicine. |
|
|---|
| Topical term or geographic name as entry element |
Immunology. |
|
|---|
| Topical term or geographic name as entry element |
Monoclonal antibodies. |
|
|---|
| Topical term or geographic name as entry element |
Biomedicine. |
|
|---|
| Topical term or geographic name as entry element |
Antibodies. |
|
|---|
| Topical term or geographic name as entry element |
Immunology. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Müller-Loennies, Sven. |
| Relator term |
editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Printed edition: |
| International Standard Book Number |
9783709108697 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-3-7091-0870-3 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
E-Book |
